See also this year's filing and all EDGAR filings for this company.
PDF Report 0001096294_2012_GFR_Pharmaceuticals_INC.pdf
Logs
| warning | The EntityCommonStockSharesOutstanding does not exist | industry.us_generic | {} |
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0001096294, GFR Pharmaceuticals INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 1,093,195 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 11,097,390 |
| 3 | remainder_Assets | 138,879 |
| 4 | LiabilitiesCurrent | 2,277,968 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 844,709 |
| 7 | CostOfGoodsAndServicesSold | 1,221,931 |
| 8 | SellingGeneralAndAdministrativeExpense | 680,568 |
| 9 | ResearchAndDevelopmentExpense | 0 |
| 10 | remainder_Expenses | 715,953 |
| 11 | remainder_Revenues | 4,674,289 |
| 12 | remainder_NetIncome | 1,510 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 12,329,464 |
| 1 | Liabilities | 3,122,677 |
| 2 | Expenses | 2,618,452 |
| 3 | Revenues | 4,674,289 |
| 4 | StockholdersEquity | 9,206,787 |
| 5 | NetIncome | 2,057,347 |
| 6 | ComprehensiveNetIncome | 2,057,347 |
| 7 | BaseVar | 11,373,196 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 2.86 |
| 9 | EconomicCapitalRatio | 3.60 |
Edgar->Model Mapping
Feature Distribution
